Clinical trial
A Multi-Center Randomized, Double-Blind Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli
NCT04191148 is registered in ClinicalTrials.gov with Locus Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center Randomized, Double-Blind Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli
- Lead sponsor
- Locus Biosciences
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 30, 2019
- Completion date
- November 19, 2020
- Enrollment
- 36 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.